Sufang Wu

1.1k total citations
39 papers, 725 citations indexed

About

Sufang Wu is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Sufang Wu has authored 39 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Cancer Research and 8 papers in Epidemiology. Recurrent topics in Sufang Wu's work include Cancer-related molecular mechanisms research (16 papers), Cervical Cancer and HPV Research (6 papers) and MicroRNA in disease regulation (5 papers). Sufang Wu is often cited by papers focused on Cancer-related molecular mechanisms research (16 papers), Cervical Cancer and HPV Research (6 papers) and MicroRNA in disease regulation (5 papers). Sufang Wu collaborates with scholars based in China, United States and Saudi Arabia. Sufang Wu's co-authors include Jiawen Zhang, Sihui Yu, Yanli Li, Xi Li, Yanan Wang, Shengjie Xu, Yuan Liu, Xiaoyun Wang, Wei Bao and Shiyu Wang and has published in prestigious journals such as Frontiers in Immunology, Cancer Letters and Toxicology and Applied Pharmacology.

In The Last Decade

Sufang Wu

38 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sufang Wu China 18 484 325 116 103 85 39 725
Wenxing Qin China 17 437 0.9× 283 0.9× 95 0.8× 171 1.7× 95 1.1× 30 780
Zhihong Ai China 12 427 0.9× 275 0.8× 88 0.8× 117 1.1× 53 0.6× 23 648
Mitzi Aguilar United States 11 369 0.8× 228 0.7× 92 0.8× 243 2.4× 84 1.0× 15 646
Lan Dai China 16 404 0.8× 233 0.7× 150 1.3× 90 0.9× 43 0.5× 39 701
Chun-Cai Gu China 13 635 1.3× 479 1.5× 74 0.6× 155 1.5× 90 1.1× 17 846
Ali E. Yesilkanal United States 8 491 1.0× 205 0.6× 73 0.6× 146 1.4× 76 0.9× 10 733
Xiangdong Hua China 11 544 1.1× 397 1.2× 43 0.4× 95 0.9× 70 0.8× 20 764
Mingzi Tan China 16 339 0.7× 176 0.5× 160 1.4× 125 1.2× 55 0.6× 28 615
Chunyang Xing China 15 555 1.1× 365 1.1× 156 1.3× 181 1.8× 64 0.8× 28 809
Monika Zajkowska Poland 14 233 0.5× 189 0.6× 140 1.2× 230 2.2× 38 0.4× 46 550

Countries citing papers authored by Sufang Wu

Since Specialization
Citations

This map shows the geographic impact of Sufang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sufang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sufang Wu more than expected).

Fields of papers citing papers by Sufang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sufang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sufang Wu. The network helps show where Sufang Wu may publish in the future.

Co-authorship network of co-authors of Sufang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Sufang Wu. A scholar is included among the top collaborators of Sufang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sufang Wu. Sufang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Sihui, et al.. (2025). Mitochondrial metabolism and cancer therapeutic innovation. Signal Transduction and Targeted Therapy. 10(1). 245–245. 13 indexed citations
2.
3.
Nie, Zhenyu, Ying Che, Jianhong Shu, et al.. (2024). The Chinese Hamster Ovary Cell-Based H9 HA Subunit Avian Influenza Vaccine Provides Complete Protection against the H9N2 Virus Challenge in Chickens. Viruses. 16(1). 163–163. 2 indexed citations
4.
5.
Ma, Mingjun, Jingfen Zhu, Yongbin Yang, et al.. (2022). The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions. Cancer Medicine. 11(6). 1542–1552. 5 indexed citations
6.
Rui, Yang, et al.. (2022). Emerging role of RNA sensors in tumor microenvironment and immunotherapy. Journal of Hematology & Oncology. 15(1). 43–43. 18 indexed citations
7.
Yu, Sihui, Xi Li, Mingjun Ma, et al.. (2022). The Immunological Contribution of a Novel Metabolism-Related Signature to the Prognosis and Anti-Tumor Immunity in Cervical Cancer. Cancers. 14(10). 2399–2399. 7 indexed citations
8.
Wu, Hao, Cong Lu, Xing Li, Xianming Xu, & Sufang Wu. (2022). Insufficient sleep disrupts glucose metabolism during pregnancy by inhibiting PGC-1α. Annals of Translational Medicine. 10(22). 1241–1241.
9.
Yu, Sihui, et al.. (2022). Cancer-associated fibroblasts-derived FMO2 as a biomarker of macrophage infiltration and prognosis in epithelial ovarian cancer. Gynecologic Oncology. 167(2). 342–353. 17 indexed citations
10.
Yu, Jing, Yue Fu, Qiuju Zhang, et al.. (2022). Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism. Laboratory Investigation. 102(12). 1335–1345. 9 indexed citations
11.
Yu, Sihui, et al.. (2021). Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers. Journal of Hematology & Oncology. 14(1). 181–181. 64 indexed citations
12.
Huang, Jingjing, Jin Wang, Hua He, et al.. (2021). Close interactions between lncRNAs, lipid metabolism and ferroptosis in cancer. International Journal of Biological Sciences. 17(15). 4493–4513. 42 indexed citations
13.
Yang, Rui, Mingjun Ma, Sihui Yu, et al.. (2021). High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation, Invasion, and Migration in Cervical Cancer. Frontiers in Oncology. 11. 742017–742017. 4 indexed citations
14.
Yu, Sihui, Xi Li, Jiawen Zhang, & Sufang Wu. (2021). Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer. Frontiers in Immunology. 12. 709493–709493. 22 indexed citations
15.
Xu, Shengjie, et al.. (2021). LSD1 silencing contributes to enhanced efficacy of anti-CD47/PD-L1 immunotherapy in cervical cancer. Cell Death and Disease. 12(4). 282–282. 39 indexed citations
16.
He, Hua, Jingjing Huang, Sufang Wu, et al.. (2021). The roles of GTPase-activating proteins in regulated cell death and tumor immunity. Journal of Hematology & Oncology. 14(1). 171–171. 27 indexed citations
17.
Zhang, Qinyi, Qingying Wang, Sufang Wu, & Jiawen Zhang. (2020). Clinical implication and immunological characterisation of the ARF-GEF family member CYTH4 in ovarian cancer. Autoimmunity. 53(8). 434–442. 6 indexed citations
18.
Li, Xi, Yanan Wang, Qi Wang, et al.. (2018). Exosomes in cancer: Small transporters with big functions. Cancer Letters. 435. 55–65. 39 indexed citations
19.
Wang, Yanan, Shiyu Wang, Yuan Liu, et al.. (2017). LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1. International Journal of Oncology. 50(3). 942–952. 24 indexed citations
20.
Zhang, Jiawen, Li Wang, Min Qiu, et al.. (2013). The Protein Levels of MCM7 and p63 in Evaluating Lesion Severity of Cervical Disease. International Journal of Gynecological Cancer. 23(2). 318–324. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenxing Qin Breakdown of academic impact, for papers by Zhihong Ai Breakdown of academic impact, for papers by Mitzi Aguilar Breakdown of academic impact, for papers by Lan Dai Breakdown of academic impact, for papers by Chun-Cai Gu Breakdown of academic impact, for papers by Ali E. Yesilkanal Breakdown of academic impact, for papers by Xiangdong Hua Breakdown of academic impact, for papers by Mingzi Tan Breakdown of academic impact, for papers by Chunyang Xing Breakdown of academic impact, for papers by Monika Zajkowska
Rankless by CCL
2026